Results 41 to 50 of about 5,366 (188)

Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: A potential therapy for primary hyperoxaluria [PDF]

open access: yes, 2005
Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: A potential therapy for primary hyperoxaluria.BackgroundPrimary hyperoxaluria is a rare genetic disorder of glyoxylate metabolism that results in overproduction of oxalate. The disease is
Kim, Daniel   +11 more
core   +1 more source

Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice. [PDF]

open access: yesPLoS ONE, 2016
Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17β-estradiol (E2) replacement can no longer upregulate glomerular ER expression by 21 ...
Simone Pereira-Simon   +6 more
doaj   +1 more source

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat [PDF]

open access: yes, 2002
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.BackgroundNonenzymatic reactions between sugars or lipids and protein and formation of advanced glycation and lipoxidation end products (AGE/ALEs) contribute to
Alderson, Nathan L.   +7 more
core   +1 more source

Studies on Nickel(II)-Pyridoxamine-Imidazole Containing Mixed Ligand Complex Systems [PDF]

open access: yesIranian Journal of Chemistry & Chemical Engineering, 2004
The stability constants of species present in the systems Ni(II)-pyridoxamine(pym)(A) and Ni(II)-pyridoxamine(pym)(A)-imidazole containing ligands(B) [B = imidazole(him),  benzimidazole(bim), histamine(hist) and L-histidine(his)] have been determined pH ...
M.A Neelakantan, M . Sivasankaran Nair
doaj  

Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes. [PDF]

open access: yesPLoS ONE, 2014
Advanced-glycation end products (AGEs) were recently implicated in vascular calcification, through a process mediated by RAGE (receptor for AGEs). Although a correlation between AGEs levels and vascular calcification was established, there is no evidence
Mathieu R Brodeur   +6 more
doaj   +1 more source

Assessment of in vitro bioaccessibility of pyridoxal, pyridoxine and pyridoxamine forms of vitamin B6 in various vegetables [PDF]

open access: yes, 2023
Vitamin B6 is defined as the sum of pyridoxal, pyridoxine and pyridoxamine vitamers. The content of each form is quite different in various types of vegetables.
Gurbuz, Murat   +5 more
core   +2 more sources

Metal complexes involving pyridoxine and pyridoxamine

open access: yes, 1978
Solid complexes of pyridoxine with Mn(II) , Cd(II) and Zn(II) have been isolated, as well as compounds containing Cu(II), Ni(II), Co(III), Cd(II) and Zn(II), and pyridoxamine in various protonated forms.
Franklin, Teresa Anne.
core   +1 more source

Pyridoxamine, a scavenger agent of carbohydrates.

open access: yes
[eng] Pyridoxamine has been found to inhibit protein glycation and to avoid the formation of advanced glycation end-products (AGEs). One of the mechanisms by which pyridoxamine can inhibit glycation involves the scavenger of carbonyl groups with ...
Adrover Estelrich, Miguel   +3 more
core   +1 more source

Rv2607 from Mycobacterium tuberculosis is a pyridoxine 5'-phosphate oxidase with unusual substrate specificity. [PDF]

open access: yesPLoS ONE, 2011
Despite intensive effort, the majority of the annotated Mycobacterium tuberculosis genome consists of genes encoding proteins of unknown or poorly understood function.
Ellene H Mashalidis   +6 more
doaj   +1 more source

Unexpected isomeric equilibrium in pyridoxamine Schiff bases

open access: yes
[eng] Pyridoxamine is a vitamin B6 derivative involved in biological reactions such as transamination, and can also act as inhibitor in protein glycation.
Adrover Estelrich, Miguel   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy